CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 8-K Event Auditor change
- 4 Option exercise Director acquired 1,900 shares (option exercise)
- 4 Option exercise Director acquired 22,000 shares (option exercise)
- 4 Open-market buy Director bought 5,000 shares at $2.10 ($10,500)
- 4 Open-market buy Director bought 1,000 shares at $2.10 ($2,100)
- 4 Option exercise Director acquired 3,356 shares (option exercise)
- 4 Option exercise Exec VP and Chief MO acquired 200 shares (option exercise)
- 4 Option exercise VP & Chief Financial Officer acquired 5,667 shares (option exercise)
- 4 Option exercise VP and GM Cell Therapy acquired 2,500 shares (option exercise)
- 4 Option exercise General Counsel & VP of BD acquired 1,896 shares (option exercise)
- 4 Option exercise President and CEO acquired 41,305 shares (option exercise)
- 8-K Event Other events
- CERTNAS Other Certification by the Nasdaq Stock Market
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Other events
- 8-A12B Other Registration of Securities
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure
Page 33 of 74 · 1,465 filings